RxDoctor Payments Data

Huan Giap, MD

Radiation Oncology · Murrells Inlet, SCNPI 1033185442

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $1,500 of the $2,496 with a category attached, or 60.1%. Reflexion Medical, Inc. accounts for 66.8% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2021 at $1,500 and has fallen 98.3% since, to $25 in 2024.

$2,496in general payments, 2019–2025

Across 8 payments — averaging $311.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Reflexion Medical, Inc.$2K
  • Varian Medical Systems, Inc.$525
  • IBA Proton Therapy, Inc.$152
  • Novocure Inc.$128
  • Teleflex LLC$25

What the payments were for

  • Speaking & faculty fees$1,50060%
  • Travel & lodging$52521%
  • Food & beverage$47119%

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Reflexion Medical, Inc.2$1,666
Varian Medical Systems, Inc.2$525
IBA Proton Therapy, Inc.2$152
Novocure Inc.1$128
Teleflex LLC1$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,496 in reported general payments places this provider in the 80th percentile of 72 radiation oncology providers in South Carolina.

See all radiation oncology providers in South Carolina

Medicare billing

Part B allowed, 2024
$385,387
Medicare patients
183
Services billed
2,226

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lidocaine Hcl ViscousLidocaine Hcl18$251
Tamsulosin Hcl25$161

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Murrells Inlet

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →